Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Medtronic
Dow
McKinsey
Baxter

Last Updated: February 2, 2023

Piramal Critical Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for PIRAMAL CRITICAL, and what generic and branded alternatives to PIRAMAL CRITICAL drugs are available?

PIRAMAL CRITICAL has twelve approved drugs.



Summary for Piramal Critical
US Patents:0
Tradenames:11
Ingredients:11
NDAs:12

Drugs and US Patents for Piramal Critical

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Piramal Critical GABLOFEN baclofen INJECTABLE;INTRATHECAL 022462-001 Nov 19, 2010 AP RX Yes Yes See Plans and Pricing See Plans and Pricing
Piramal Critical ENFLURANE enflurane LIQUID;INHALATION 074396-001 Jul 29, 1994 DISCN No No See Plans and Pricing See Plans and Pricing
Piramal Critical ROCURONIUM BROMIDE rocuronium bromide INJECTABLE;INJECTION 210437-001 Aug 13, 2019 AP RX No No See Plans and Pricing See Plans and Pricing
Piramal Critical CISATRACURIUM BESYLATE cisatracurium besylate INJECTABLE;INJECTION 215516-001 May 24, 2022 AP RX No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for PIRAMAL CRITICAL drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe for Injection 100 mcg/vial and 500 mcg/vial ➤ Subscribe 2015-04-14
➤ Subscribe for Injection 200 mcg/vial ➤ Subscribe 2015-05-01
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
McKinsey
Boehringer Ingelheim
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.